# Annette Oturai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/annette-oturai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,429 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 44 |
| i10-index | 86 |
| OpenAlex ID | https://openalex.org/A5108222986 |
| Works | 115 |

## Researcher papers

- [Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis](https://scholariq.org/papers/genetic-risk-and-a-primary-role-for-cell-mediated-immune-mechanisms-in-multiple/)
- [Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis](https://scholariq.org/papers/analysis-of-immune-related-loci-identifies-48-new-susceptibility-variants-for/)
- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [Multiple Sclerosis Severity Score](https://scholariq.org/papers/multiple-sclerosis-severity-score/)
- [Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis](https://scholariq.org/papers/variation-in-interleukin-7-receptor-chain-il7r-influences-risk-of-multiple/)
- [Factors influencing success of clinical genome sequencing across a broad spectrum of disorders](https://scholariq.org/papers/factors-influencing-success-of-clinical-genome-sequencing-across-a-broad/)
- [Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene](https://scholariq.org/papers/genome-wide-association-study-in-a-high-risk-isolate-for-multiple-sclerosis/)
- [Locus for severity implicates CNS resilience in progression of multiple sclerosis](https://scholariq.org/papers/locus-for-severity-implicates-cns-resilience-in-progression-of-multiple/)
- [DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis](https://scholariq.org/papers/dna-methylation-as-a-mediator-of-hla-drb1-15-01-and-a-protective-variant-in/)
- [Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk](https://scholariq.org/papers/low-frequency-and-rare-coding-variation-contributes-to-multiple-sclerosis-risk/)
- [Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation](https://scholariq.org/papers/perfluorinated-substances-risk-factors-for-multiple-sclerosis-and-cellular/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.